Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
Dermatology
•
Hidradenitis Suppurativa
•
Primary Care
How would you manage a patient with hidradenitis suppurativa and inflammatory arthritis (RA vs. PsA)?
Pt has not responded to Humira or Cosentyx. Pt is declining to have any infusion options.
Related Questions
What is your approach to diagnosing and managing methotrexate-induced alopecia?
How would you approach management of a patient who develops squamous cell skin cancer while on abatacept?
How do you approach management of DMARDs and biologics in a patient with active RA, but frequent recurrent simple UTIs?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
How do you approach treatment intensification in patients with RA and low disease activity but not in remission, considering the potential risks of increased immunosuppression?
How would you approach management of a patient with longstanding history of SLE, but having active psoriasis?
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?